Skip to main content
Clinical Trials/TCTR20230502003
TCTR20230502003
Not yet recruiting
Phase 3

Fluid bolus in suspected sepsis patients with hyperlactatemia: Open-labeled, Randomized controlled trial

Khon Kaen University0 sites224 target enrollmentMay 2, 2023

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Patients who suspected sepsis with hyperlactatemia in Emergency department of Srinagarind hospital, Khon Kaen university, Khon Kaen Thailand
Sponsor
Khon Kaen University
Enrollment
224
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 2, 2023
End Date
June 30, 2024
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\) Patients who suspected sepsis: SIRS criteria \> or \= 2 points \+ suspected or confirmed source of infection.
  • 2\) Hyperlactatemia: Point\-of\-care serum lactate 2\-4 mmol/L from arterial or venous blood gas.
  • 3\) Ages over or equal 18 years old.

Exclusion Criteria

  • 1\) Congestive heart failure or sign of volume overload or patient who had past history of low ejection fraction (%EF less than 40%) or Functional class IV
  • 2\) ESRD with and without RRT
  • 3\) Hypotension due to any cause (SBP \< 90 mmHg or MAP \< 65 mmHg)
  • 4\) Morbid obesity (BMI \> or \= 40 kg/m2\)
  • 5\) Pregnancy
  • 6\) Transferred from another hospital
  • 7\) Administration of IV fluid before ED arrival
  • 8\) Refused to participate or DNR
  • 9\) Suspected type B lactic acidosis e.g., toxin\-induced (metformin, isoniazid, NRTIs), liver failure or thiamine deficiency

Outcomes

Primary Outcomes

Not specified

Similar Trials